Parallel Advisors’s Maravai LifeSciences MRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-787
| Closed | -$1.74K | – | 3630 |
|
|
2025
Q1 | $1.74K | Sell |
787
-213
| -21% | -$471 | ﹤0.01% | 2997 |
|
|
2024
Q4 | $5.45K | Sell |
1,000
-432
| -30% | -$2.35K | ﹤0.01% | 2588 |
|
|
2024
Q3 | $11.9K | Sell |
1,432
-89
| -6% | -$740 | ﹤0.01% | 2316 |
|
|
2024
Q2 | $10.9K | Buy |
1,521
+71
| +5% | +$508 | ﹤0.01% | 2265 |
|
|
2024
Q1 | $12.6K | Sell |
1,450
-560
| -28% | -$4.86K | ﹤0.01% | 2208 |
|
|
2023
Q4 | $13.2K | Buy |
2,010
+902
| +81% | +$5.91K | ﹤0.01% | 2169 |
|
|
2023
Q3 | $11.1K | Buy |
1,108
+978
| +752% | +$9.78K | ﹤0.01% | 2144 |
|
|
2023
Q2 | $1.62K | Sell |
130
-907
| -87% | -$11.3K | ﹤0.01% | 2813 |
|
|
2023
Q1 | $14.5K | Buy |
1,037
+163
| +19% | +$2.28K | ﹤0.01% | 1974 |
|
|
2022
Q4 | $12.5K | Buy |
874
+727
| +495% | +$10.4K | ﹤0.01% | 1942 |
|
|
2022
Q3 | $4K | Buy |
+147
| New | +$4K | ﹤0.01% | 2372 |
|